Vaxcyte (PCVX) Other Non-Current Liabilities (2019 - 2025)
Vaxcyte's (PCVX) quarterly Other Non-Current Liabilities came in at $100000.0 in Q4 2025, little changed year-on-year from $100000.0 in Q4 2024, and little changed on a QoQ basis from $100000.0 in Q4 2024.
Vaxcyte (PCVX) Other Non-Current Liabilities (2019 - 2025) Analysis & Trends
Vaxcyte (PCVX) has 7 years of Other Non-Current Liabilities data on file, last reported at $100000.0 in Q4 2025.
- On a quarterly basis, Other Non-Current Liabilities changed 0.0% year-over-year to $100000.0 in Q4 2025; TTM through Dec 2025 was $100000.0, a 0.0% change from a year earlier, with the FY2025 full-year figure at $100000.0, changed 0.0% from the prior year.
- Other Non-Current Liabilities for Q4 2025 stood at $100000.0, roughly flat from $100000.0 in the prior quarter.
- Over the last five years, Other Non-Current Liabilities for PCVX reached as high as $103000.0 in Q1 2021 and fell as low as $2000.0 in Q3 2023.
- Historically, Other Non-Current Liabilities has averaged $68769.2 across 5 years, with a median of $93000.0 in 2022.
- Across the five-year window, Other Non-Current Liabilities sank 97.75% in 2023 and changed 0.0% in 2025, its largest moves.
- Year by year, Other Non-Current Liabilities stood at $96000.0 in 2021, then slumped by 90.62% to $9000.0 in 2022, then tumbled by 77.78% to $2000.0 in 2023, then soared by 4900.0% to $100000.0 in 2024, then changed by 0.0% to $100000.0 in 2025.
- Per Business Quant data, the three most recent Other Non-Current Liabilities figures were $100000.0 in Q4 2025, $100000.0 in Q4 2024, and $2000.0 in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Vaxcyte | 7.64 Bn | 7.64 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 100,000.00 |
| Dec 31, 2024 | 100,000.00 |
| Sep 30, 2023 | 2,000.00 |
| Jun 30, 2023 | 5,000.00 |
| Mar 31, 2023 | 7,000.00 |
| Dec 31, 2022 | 9,000.00 |
| Sep 30, 2022 | 89,000.00 |
| Jun 30, 2022 | 92,000.00 |
| Mar 31, 2022 | 93,000.00 |
| Dec 31, 2021 | 96,000.00 |
| Sep 30, 2021 | 98,000.00 |
| Jun 30, 2021 | 100,000.00 |
| Mar 31, 2021 | 103,000.00 |
| Dec 31, 2020 | 112,000.00 |
| Sep 30, 2020 | 128,000.00 |
| Jun 30, 2020 | 136,000.00 |
| Dec 31, 2019 | 242,000.00 |